Managing Editor, Medical Reviewer & Writer

About Dr. Hussein Al-Kenani
Dr. Hussein Al-Kenani, MBChB, is a physician, medical educator, and editorial professional specializing in cardiovascular health, preventive medicine, and lifestyle-based disease management.
As Managing Editor and Medical Reviewer at AORTA, he plays a leading role in ensuring the accuracy, integrity, and accessibility of all published materials.
With a focus on transforming complex cardiovascular research into practical, evidence-based education, Dr. Hussein Al-Kenani is dedicated to advancing global heart health through scientific communication and prevention.
Professional Background
Dr. Hussein Al-Kenani earned his Doctor of Medicine (MBChB) from Jabir ibn Hayyan University for Medical and Pharmaceutical Sciences in 2024.
He also holds Basic Life Support (BLS) and Advanced Cardiac Life Support (ACLS) certifications from the American Heart Association Academy (2023).
In addition to his editorial and clinical expertise, Dr. Hussein Al-Kenani serves as a Medical Lecturer at Warith Al-Anbiyaa Medical College, where he integrates guideline-based cardiovascular medicine and preventive strategies into medical education.
His academic work emphasizes early intervention, patient empowerment, and the integration of research into practical teaching.
At AORTA, Dr. Al-Kenani combines his medical insight with advanced editorial strategy—reviewing, editing, and developing educational materials that promote clarity, scientific rigor, and public trust.
Areas of Expertise
- Cardiovascular and Preventive Medicine
- Internal Medicine and Public Health
- Lifestyle Medicine and Nutrition
- Medical Writing and Digital Health Communication
- Evidence Synthesis and Systematic Review
- Editorial Quality Assurance and Peer Review
Role at AORTA
As part of AORTA’s Editorial and Medical Communications Division, Dr. Al-Kenani is responsible for:
- Reviewing and verifying cardiovascular education materials for clinical accuracy and ethical compliance.
- Leading editorial workflows and ensuring adherence to E-E-A-T principles (Experience, Expertise, Authoritativeness, Trustworthiness).
- Contributing original content to AORTA’s professional education series and patient-focused materials.
- Collaborating across disciplines to make cardiovascular health education clear, actionable, and evidence-driven.
Through these contributions, Dr. Hussein Al-Kenani strengthens AORTA’s position as a trusted global leader in heart-health education.
Philosophy & Vision
Guided by the belief that education is the foundation of prevention, Dr. Al-Kenani emphasizes the role of clear, credible communication in reducing the global burden of cardiovascular disease.
He advocates for bridging clinical science and public understanding, ensuring that every reader—whether a patient, student, or healthcare professional—can access accurate, actionable, and compassionate information.
“Heart health begins with awareness—and awareness begins with knowledge.”
Published Contributions
Authored, Reviewed, and Editorially Contributed Content at AORTA
Dr. Al-Kenani’s work spans both professional and public education initiatives within AORTA.
He contributes extensively to the organization’s “For Professionals” section, developing specialized materials designed to inform and empower medical practitioners.
AHA Life’s Essential 8: Comprehensive Cardiovascular Prevention Framework
Abstract The American Heart Association’s Life’s Essential 8 (LE8) represents a comprehensive, updated cardiovascular prevention framework for assessing and promoting...
Read MoreInfective Endocarditis Management: ESC/AHA 2023 Guidelines
Abstract Infective endocarditis (IE) remains a severe microbial infection of the endocardium with high morbidity and mortality, necessitating rapid, guideline-driven...
Read MoreESC 2023 Valvular Heart Disease Guidelines: Key Decisions & Intervention Timing
Abstract The 2023 European Society of Cardiology (ESC) Guidelines for the management of Valvular Heart Disease (VHD) present significant updates...
Read MoreCardio-Kidney-Metabolic Syndrome: ACC CKM Staging & Management
Abstract This article reviews the clinical implications of the Cardio-Kidney-Metabolic (CKM) Syndrome continuum, focusing on the 2023 American College of...
Read MoreKDIGO 2024 CKD Guidelines: A Framework for Cardiorenal Integration
Abstract The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (CKD) represents a pivotal...
Read MoreADA 2024 Standards of Care: Cardiorenal Protection Updates
Abstract The 2024 updates to the American Diabetes Association (ADA) Standards of Care reflect a paradigm shift from purely glycemic...
Read MoreACC/AHA 2023 Lipid Management: Risk-Based Strategy, Lp(a), and apoB
Abstract The ACC/AHA 2023 lipid management guidelines consolidate the risk-based approach to atherosclerotic cardiovascular disease (ASCVD) prevention while integrating novel...
Read MoreESC 2023 Dyslipidemia: New LDL-C Targets & Non-Statin Rx
Abstract The European Society of Cardiology (ESC) 2023 Guidelines for the Management of Dyslipidaemias represent a significant intensification of therapeutic...
Read MoreHypertension in Pregnancy: Current ESC Standards & Evolving Evidence
Abstract Objective: Hypertensive disorders of pregnancy (HDP), including preeclampsia and chronic hypertension, remain a dominant cause of maternal and neonatal...
Read MoreLatest AHA/ACC Hypertension Guidelines: CKM Integration & Comorbidity Targets
Abstract This article summarizes the Latest AHA/ACC Hypertension Guidelines, focusing on critical updates for clinical practice, particularly the integration of...
Read MoreESC/ESH 2023 Hypertension Guidelines: Key Updates on Targets and Therapy
Abstract The 2023 Guidelines for the management of arterial hypertension, co-published by the European Society of Cardiology (ESC) and the...
Read MoreSVT Catheter Ablation: Indications, Outcomes, and Monitoring
Abstract Catheter ablation has emerged as the definitive, first-line therapeutic strategy for many forms of supraventricular tachycardia (SVT), shifting the...
Read More2023 Bradyarrhythmias Pacing Guidelines: Key Indications and Protocols
Abstract The management of bradyarrhythmias and cardiac conduction disorders is continuously refined by evidence from major clinical trials, necessitating regular...
Read More2023 Ventricular Arrhythmia Guidelines: Key Updates on ICD and Prevention
Abstract The 2023 AHA/ACC/HRS Guideline for the Management of Patients With Ventricular Arrhythmias (VA) and the Prevention of Sudden Cardiac...
Read MoreESC 2024 Atrial Fibrillation Guidelines: Stroke Prevention and Rhythm Control
Abstract This review summarizes the critical updates and clinical implications derived from the 2024 European Society of Cardiology (ESC) Guidelines...
Read MoreCardiac Transplantation and Mechanical Circulatory Support in Advanced HF
Abstract Advanced heart failure (AHF), refractory to guideline-directed medical therapy (GDMT), represents a critical clinical challenge with high morbidity and...
Read MoreCardiomyopathy Review: 2023 ESC Guidelines & AHA/ACC Classification and Management
Abstract Cardiomyopathies are a heterogeneous group of disorders associated with structural and functional abnormalities of the myocardium, leading to potentially...
Read MoreAcute Decompensated Heart Failure Management: Guideline-Driven Strategy
Abstract Acute decompensated heart failure (ADHF) is a leading cause of hospitalization with high morbidity and mortality, necessitating rapid, evidence-based...
Read MoreAHA/ACC/HFSA 2022 Heart Failure Guidelines: U.S. vs. Global Practice
Abstract The management of heart failure (HF) has been fundamentally redefined by successive international guidelines. This article provides a comparative...
Read MoreESC Heart Failure Guidelines: 2021 Standards & 2023 Focused Update
Abstract Objective: The clinical management of heart failure (HF) is currently governed by the 2021 European Society of Cardiology (ESC)...
Read MoreAspirin Primary and Secondary Prevention: Updated AHA/ACC/ESC Guidelines
Abstract This clinical review synthesizes the evolving international guidelines regarding the use of low-dose aspirin for primary and secondary cardiovascular...
Read MoreDual Antiplatelet Therapy Duration and Selection: Balancing Risk in ACS and PCI
Abstract The management of patients with acute coronary syndromes (ACS) or those undergoing percutaneous coronary intervention (PCI) necessitates balancing the...
Read MoreRevascularization in Stable CAD: ESC/AHA/ACC Comparative Guidance (PCI vs. CABG)
Abstract Revascularization strategies for Stable Coronary Artery Disease (CAD) aim to improve symptoms, enhance quality of life, and potentially improve...
Read MoreChronic Coronary Disease Guidelines 2023: ACC/AHA Secondary Prevention Update
Abstract: Key Updates in Long-Term Management The 2023 AHA/ACC/Multisociety Guideline for the Management of Patients with Chronic Coronary Disease (CCD)...
Read More






















